Medical Devices industry venture financing deals total $936.83m in North America in January 2021

25 February 2021 (Last Updated February 25th, 2021 20:04)

Total medical devices industry venture financing deals worth $936.83m were announced in North America in January 2021, led by $190m venture financing of Valo Health, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked an increase of 2.9% over the previous month of $910.37m and a rise of 13.2% when compared with the last 12-month average of $827.43m.

North America held an 82.18% share of the global medical devices industry venture financing deal value that totalled $1.14bn in January 2021. With an 81.52% share and deals worth $929.33m, the US was the top country in North America’s venture financing deal value across medical devices industry.

In terms of venture financing deal activity, North America recorded 27 deals during January 2021, marking a decrease of 42.55% over the previous month and a drop of 52.63% over the 12-month average. The US recorded 24 deals during the month.

North America medical devices industry venture financing deals in January 2021: Top deals

The top five medical devices industry venture financing deals accounted for 68.5% of the overall value during January 2021.

The combined value of the top five medical devices venture financing deals stood at $642m, against the overall value of $936.83m recorded for the month.

The top five medical devices industry venture financing deals of January 2021 tracked by GlobalData were:

1) Atinum Investment, HBM Healthcare Investments, Invus Public Equities, Mirae Asset Capital and Public Sector Pension Investment Board’s $190m venture financing of Valo Health

2) The $167m venture financing of Color Genomics by General Catalyst Partners, T Rowe Price Associates and Viking Global Investors

3) AV8 Ventures, Cowen Healthcare Investments, Foresite Capital Management, Illumina Ventures, Menlo Ventures, Northpond Ventures, Orbimed Advisors, Osage University Partners, Rock Springs Capital Management, Samsara BioCapital, T Rowe Price Associates and Windham Venture Partners’ $100m venture financing of Delfi Diagnostics

4) The $100m venture financing of SPaige.AI by Casdin Capital and Johnson & Johnson Innovation – JJDC

5) Ally Bridge Group and Perceptive Advisors’ venture financing of IsoPlexis for $85m.